OPK Opko Health, Inc.
$1.66▲ +0.00%
Healthcare
Other
After hours
$1.64▼ -1.14%
Oct 30, 7:48 PM ET
Volume 2.15M
Avg Volume (10D) 2.76M
Key Metrics & Fundamentals
Market Cap
$1.24B
P/E Ratio
–
Div Yield
0.00%
52W Range
0.98 - 1.77
% vs 50 MA
6.18%
% vs 200 MA
23.53%
RSI-14
58.9
MACD Histogram
+0.0100
Beta (1Y vs SPY)
0.89
Free Cash Flow
-$46.50M
Gross Rev
$163.58M
Gross Profit
$80.02M
EBITDA
$2.38M
COGS
$83.56M
Operating Exp
$105.06M
Operating Income
-$25.04M
EBIT
-$25.04M
Pretax Income
-$13.40M
Net Income
-$8.42M
EPS (Diluted)
-0.01
Price & Volume History
Loading chart…
Recent News
DexCom Stock Up on Q3 Earnings & Revenue Beat, Margins Rise
Zacks · Oct 30, 2026 10:00 AM ET
DaVita Q3 Earnings Beat Estimates on IKC Strength, Revenues Rise Y/Y
Zacks · Oct 30, 2026 9:57 AM ET
Reasons to Hold Hinge Health Stock in Your Portfolio for Now
Zacks · Oct 29, 2026 12:24 PM ET
Baxter Q3 Earnings Beat on Broad-Based Growth, '26 Outlook Raised
Zacks · Oct 29, 2026 10:48 AM ET
GEHC Q3 Earnings Beat Estimates on Strong Growth, '26 View Raised
Zacks · Oct 28, 2026 10:05 AM ET
OPKO Health to Report Third Quarter 2026 Financial Results on November 4, 2026
GlobeNewswire · Oct 28, 2026 8:52 AM ET
Cencora to Acquire AON in $2.4B Deal to Expand Oncology Network
Zacks · Oct 28, 2026 8:37 AM ET
Ecolab Q3 Earnings In-Line With Estimates, Revenues Increase Y/Y
Zacks · Oct 27, 2026 1:30 PM ET
Here's Why You Should Hold PacBio Stock in Your Portfolio for Now
Zacks · Oct 27, 2026 1:29 PM ET
Waters & Labcorp Expand Access to FDA-Approved HPV Screening Tests
Zacks · Oct 27, 2026 11:31 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See OPK's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.